Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solid Organ Transplant Recipients”

134 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 134 results

Large-scale testing (Phase 3)Ended earlyNCT01761201
What this trial is testing

"Efficacy and Safety of Levofloxacin vs Isoniazid in Latent Tuberculosis Infection in Liver Transplant Patients".

Who this might be right for
Latent Tuberculosis InfectionInfection in Solid Organ Transplant Recipients
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 68
Not applicableStudy completedNCT01558037
What this trial is testing

Cell Mediated Immunity With Risk of Cytomegalovirus (CMV) in Solid Organ Transplant Recipients

Who this might be right for
Awaiting Organ TransplantInfection in Solid Organ Transplant Recipients
Michael Ison 113
Not applicableStudy completedNCT05189340
What this trial is testing

Development of Discharge Education Video for Solid Organ Transplant Recipients

Who this might be right for
Educational ActivitiesOrgan Transplants
Johns Hopkins University 24
Not applicableStudy completedNCT00518778
What this trial is testing

Fusariosis in Solid-Organ Transplant Recipients

Who this might be right for
Solid Organ TransplantFusariosis
University of Pittsburgh 50
Not applicableStudy completedNCT00026767
What this trial is testing

Surveillance of Fungal Infections in Bone Marrow/Stem Cell and Organ Transplant Recipients

Who this might be right for
Fungus Disease
National Cancer Institute (NCI) 217
Not applicableStudy completedNCT00170170
What this trial is testing

Risk Factors for Cytomegalovirus Disease in Solid Organ Transplantation

Who this might be right for
TransplantationInfectionCytomegalovirus Infections
Mayo Clinic 500
Not applicableActive Not RecruitingNCT01527591
What this trial is testing

Pneumococcal Conjugate Vaccine 13 (Prevnar13®) in Children Who Are Solid Organ Transplant Recipients (SOT)

Who this might be right for
Infection in Solid Organ Transplant Recipients
University of California, Los Angeles 17
Not applicableStudy completedNCT05116748
What this trial is testing

COVID19 Vaccine in SOT Adult Recipients

Who this might be right for
COVID-19Vaccine Adverse ReactionVaccine Response Impaired+4 more
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 364
Post-approval studies (Phase 4)Active Not RecruitingNCT05557370
What this trial is testing

Immunogenicity of HPV Vaccine in Transplant Recipients.

Who this might be right for
Chronic Kidney DiseasesKidney Transplant
Medical College of Wisconsin 30
Testing effectiveness (Phase 2)Study completedNCT02900976
What this trial is testing

Rituximab and LMP-Specific T-Cells in Treating Pediatric Solid Organ Recipients With EBV-Positive, CD20-Positive Post-Transplant Lymphoproliferative Disorder

Who this might be right for
EBV-Related Post-Transplant Lymphoproliferative DisorderMonomorphic Post-Transplant Lymphoproliferative DisorderPolymorphic Post-Transplant Lymphoproliferative Disorder+4 more
Children's Oncology Group 18
Testing effectiveness (Phase 2)Ended earlyNCT00555321
What this trial is testing

Belatacept in Liver Transplant Recipients

Who this might be right for
Immunosuppression in Solid Organ Transplant
Bristol-Myers Squibb 260
Testing effectiveness (Phase 2)Looking for participantsNCT06599658
What this trial is testing

COVID-19 Booster and IIV Schedule in Immunocompromised Hosts

Who this might be right for
COVID 19InfluenzaRheumatoid Arthritis (RA)+5 more
McGill University Health Centre/Research Institute of the McGill University Health Centre 660
Not applicableStudy completedNCT05124509
What this trial is testing

Immune Response to Third Dose of COVID-19 Vaccine in Solid Organ Transplant

Who this might be right for
COVID-19SARS-CoV-2 InfectionSolid Organ Transplant+1 more
Pontificia Universidad Catolica de Chile 147
Not applicableUnknownNCT06242496
What this trial is testing

Brain Abscesses in Transplant Recipients: a Multicentre Retrospective Study (BAT-STUDY)

Who this might be right for
Brain Abscess
Assistance Publique - Hôpitaux de Paris 200
Large-scale testing (Phase 3)Study completedNCT00677677
What this trial is testing

Safety and Immunogenicity of Human Papillomavirus (HPV) Vaccine in Solid Organ Transplant Recipients

Who this might be right for
Transplant
University of Alberta 50
Post-approval studies (Phase 4)Study completedNCT01371331
What this trial is testing

Determine Pharmacokinetics of Children Receiving Modigraf (Tacrolimus Granules) Following Solid Organ Transplantation

Who this might be right for
Kidney TransplantationHeart TransplantationLiver Transplantation
Astellas Pharma Europe Ltd. 52
Very early researchLooking for participantsNCT03665675
What this trial is testing

Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation RecipientCytomegalovirusDonor+2 more
Sumithira Vasu 20
Testing effectiveness (Phase 2)Looking for participantsNCT06853184
What this trial is testing

Study Evaluating the Efficacy and Safety of Artesunate

Who this might be right for
CMV Infection
Amivas Inc. 90
Not applicableStudy completedNCT03438058
What this trial is testing

Complement-activating Anti-human Leucocyte Antigen Donor Specific Antibodies in Solid Organ Transplantation

Who this might be right for
Organ Transplant Recipients
Paris Translational Research Center for Organ Transplantation 7,547
Testing effectiveness (Phase 2)Study completedNCT01329185
What this trial is testing

Treating Kidney Donors With Valganciclovir to Reduce Viral Transmission to Recipients

Who this might be right for
EBV ViremiaCMV Viremia
University of Minnesota 17
Next Page